<?xml version="1.0" encoding="UTF-8"?>
<ref id="B82">
 <label>82.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Zheng</surname>
    <given-names>XW</given-names>
   </name>
   <span xml:space="preserve" class="x" xmlns="http://www.w3.org/1999/xhtml">, </span>
   <name name-style="western">
    <surname>Tao</surname>
    <given-names>G</given-names>
   </name>
   <span xml:space="preserve" class="x" xmlns="http://www.w3.org/1999/xhtml">, </span>
   <name name-style="western">
    <surname>Zhang</surname>
    <given-names>YW</given-names>
   </name>
   <span xml:space="preserve" class="x" xmlns="http://www.w3.org/1999/xhtml">, </span>
   <name name-style="western">
    <surname>Yang</surname>
    <given-names>GN</given-names>
   </name>
   <span xml:space="preserve" class="x" xmlns="http://www.w3.org/1999/xhtml">, </span>
   <name name-style="western">
    <surname>Huang</surname>
    <given-names>P</given-names>
   </name>
  </person-group>
  <article-title>Drug interaction monitoring of lopinavir / ritonavir in COVID-19 patients with cancer</article-title>. 
  <source>Zhonghua Nei Ke Za Zhi</source>
  <volume>59</volume>(
  <issue>8(4)</issue>), 
  <fpage>420</fpage>â€“
  <lpage>422</lpage> (
  <year>2020</year>).
 </mixed-citation>
</ref>
